Didobi commentary in news article – U.S. Developers Swoop In To Help Build Europe’s Budding Life Sciences Industry
Since last January, £2.7B (or $3.4B) has been invested in British biotech as new deals and development pop up in the Golden Triangle of key markets: Oxford, Cambridge and London,